A comparative study on production of extracellular hydrolytic enzymes of Candida species isolated from patients with surgical site infection and from healthy individuals and their co-relation with antifungal drug resistance

Table 7 Antifungal Susceptibility Profile of Candida spp. Isolated from Surgical Wound Patients

Candida spp.	Fluconazole		Voriconazole		Itraconazole
	S	R	S	R	S	R
C. albicans (n = 54)	48 (88.88%)	6 (11.11%)	54 (100%)	0 (0%)	53 (98.14)	1 (1.85%)
C. glabrata (n = 32)	26 (81.25%)	6 (18.75%)	29 (90.62%)	3 (9.37%)	28 (87.5)	4 (12.5%)
C. tropicalis (n = 12)	11 (91.66%)	1 (8.33%)	11 (91.66%)	1 (8.33%)	10 (83.33%)	2 (16.66%)
C. krusei (n = 13)	0 (0%)	13 (100%)	12 (92.30%)	1 (7.69%)	13 (100%)	0 (0%)
C. parapsilosis (n = 17)	17 (100%)	0 (0%)	17 (100%)	0 (0%)	17 (100)	0 (0%)

ISSN: 1471-2180